A review of the pharmacokinetic and pharmacological properties of a once-yearly administered histrelin acetate implant in the treatment of prostate cancer. Review uri icon

Overview

publication date

  • March 1, 2009

Research

keywords

  • Antineoplastic Agents, Hormonal
  • Gonadotropin-Releasing Hormone
  • Prostatic Neoplasms

Identity

Scopus Document Identifier

  • 60649086627

Digital Object Identifier (DOI)

  • 10.1111/j.1464-410X.2009.08383.x

PubMed ID

  • 19228147

Additional Document Info

volume

  • 103 Suppl 2